{
    "nctId": "NCT04257396",
    "briefTitle": "Carbon-Fibre Accessory (CARA) for Supine Breast Positioning to Reduce Toxicity in Whole Breast Radiotherapy",
    "officialTitle": "Multicentre Randomized Controlled Trial Of A Carbon-Fibre Adjustable Reusable Accessory (CARA) For Supine Breast Positioning To Reduce Toxicity In Whole Breast Adjuvant Radiotherapy",
    "overallStatus": "RECRUITING",
    "conditions": "Adjuvant Radiotherapy for Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "OTHER",
    "enrollmentCount": 220,
    "primaryOutcomeMeasure": "Rates of moist desquamation in the infra-mammary fold",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Age 18 or older.\n* Able to provide informed consent\n* ECOG performance status 0 - 2\n* Stage 0-3 invasive breast cancer or DCIS scheduled to received adjuvant radiotherapy to the whole breast\n* Any infra-mammary skin fold of \\>= 0.5 cm in the supine treatment position and/or palpable lateral breast tissue falling posterior to the mid-axilla line while in supine or treatment position.\n\nExclusion Criteria:\n\n* Inability to give informed consent or comply with experimental arm of trial\n* Previous RT to either breast or to the chest\n* Planned boost to infra mammary area\n* Use of Mepitel while on treatment\n* Failure to heal surgical wound or significant post-operative wound infection\n* Presence of significant connective tissue disease (e.g. systemic sclerosis, SLE)\n* Known radiation hypersensitivity phenotype (e.g. ataxia telangiectasia etc.)\n* Breast reconstruction\n* Planned partial breast irradiation, unless the treated area includes the infra-mammary fold",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}